載入...
Semapimod sensitizes glioblastoma tumors to ionizing radiation by targeting microglia.
Glioblastoma is the most malignant and lethal form of astrocytoma, with patients having a median survival time of approximately 15 months with current therapeutic modalities. It is therefore important to identify novel therapeutics. There is mounting evidence that microglia (specialized brain-reside...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science (PLoS)
2014-01-01
|
| 叢編: | PLoS ONE |
| 在線閱讀: | http://europepmc.org/articles/PMC4015930?pdf=render |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|